Joincare Pharmaceutical Group Industry Co Ltd - Asset Resilience Ratio
Joincare Pharmaceutical Group Industry Co Ltd (600380) has an Asset Resilience Ratio of 1.86% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Joincare Pharmaceutical Group Industry C working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1997–2025)
This chart shows how Joincare Pharmaceutical Group Industry Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 600380 total assets.
Liquid Assets Composition Over Time
This chart breaks down Joincare Pharmaceutical Group Industry Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore how much of Joincare Pharmaceutical Group Industry C's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥644.48 Million | 1.86% |
| Total Liquid Assets | CN¥644.48 Million | 1.86% |
Asset Resilience Insights
- Limited Liquidity: Joincare Pharmaceutical Group Industry Co Ltd maintains only 1.86% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Joincare Pharmaceutical Group Industry Co Ltd Industry Peers by Asset Resilience Ratio
Compare Joincare Pharmaceutical Group Industry Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM |
Drug Manufacturers - Specialty & Generic | 2.79% |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 2.51% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Harbin Pharmaceutical Group Co Ltd
SHG:600664 |
Drug Manufacturers - Specialty & Generic | 0.97% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Annual Asset Resilience Ratio for Joincare Pharmaceutical Group Industry Co Ltd (1997–2025)
The table below shows the annual Asset Resilience Ratio data for Joincare Pharmaceutical Group Industry Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 4.78% | CN¥1.69 Billion ≈ $247.90 Million |
CN¥35.41 Billion ≈ $5.18 Billion |
+4.53pp |
| 2024-12-31 | 0.25% | CN¥89.36 Million ≈ $13.08 Million |
CN¥35.72 Billion ≈ $5.23 Billion |
-1.10pp |
| 2023-12-31 | 1.35% | CN¥489.28 Million ≈ $71.60 Million |
CN¥36.36 Billion ≈ $5.32 Billion |
+1.04pp |
| 2022-12-31 | 0.31% | CN¥109.02 Million ≈ $15.95 Million |
CN¥35.73 Billion ≈ $5.23 Billion |
-0.29pp |
| 2021-12-31 | 0.59% | CN¥184.64 Million ≈ $27.02 Million |
CN¥31.10 Billion ≈ $4.55 Billion |
+0.49pp |
| 2020-12-31 | 0.10% | CN¥28.33 Million ≈ $4.15 Million |
CN¥28.16 Billion ≈ $4.12 Billion |
+0.03pp |
| 2019-12-31 | 0.07% | CN¥18.12 Million ≈ $2.65 Million |
CN¥25.44 Billion ≈ $3.72 Billion |
+0.01pp |
| 2018-12-31 | 0.06% | CN¥15.93 Million ≈ $2.33 Million |
CN¥24.99 Billion ≈ $3.66 Billion |
+0.02pp |
| 2017-12-31 | 0.04% | CN¥8.73 Million ≈ $1.28 Million |
CN¥22.21 Billion ≈ $3.25 Billion |
+0.00pp |
| 2016-12-31 | 0.04% | CN¥6.02 Million ≈ $880.78K |
CN¥16.07 Billion ≈ $2.35 Billion |
-0.01pp |
| 2015-12-31 | 0.05% | CN¥6.59 Million ≈ $964.21K |
CN¥13.80 Billion ≈ $2.02 Billion |
-0.01pp |
| 2014-12-31 | 0.05% | CN¥6.42 Million ≈ $939.97K |
CN¥12.08 Billion ≈ $1.77 Billion |
-0.05pp |
| 2013-12-31 | 0.11% | CN¥11.34 Million ≈ $1.66 Million |
CN¥10.75 Billion ≈ $1.57 Billion |
-0.50pp |
| 2012-12-31 | 0.61% | CN¥59.32 Million ≈ $8.68 Million |
CN¥9.75 Billion ≈ $1.43 Billion |
+0.11pp |
| 2011-12-31 | 0.50% | CN¥44.34 Million ≈ $6.49 Million |
CN¥8.81 Billion ≈ $1.29 Billion |
-0.31pp |
| 2010-12-31 | 0.81% | CN¥57.87 Million ≈ $8.47 Million |
CN¥7.11 Billion ≈ $1.04 Billion |
+0.02pp |
| 2009-12-31 | 0.80% | CN¥48.89 Million ≈ $7.15 Million |
CN¥6.15 Billion ≈ $899.35 Million |
-3.13pp |
| 2008-12-31 | 3.92% | CN¥228.39 Million ≈ $33.42 Million |
CN¥5.82 Billion ≈ $851.85 Million |
-11.66pp |
| 2007-12-31 | 15.58% | CN¥937.11 Million ≈ $137.13 Million |
CN¥6.01 Billion ≈ $880.09 Million |
+11.95pp |
| 2006-12-31 | 3.63% | CN¥172.20 Million ≈ $25.20 Million |
CN¥4.75 Billion ≈ $694.45 Million |
-2.02pp |
| 2005-12-31 | 5.64% | CN¥247.91 Million ≈ $36.28 Million |
CN¥4.39 Billion ≈ $642.68 Million |
-8.08pp |
| 2004-12-31 | 13.72% | CN¥605.72 Million ≈ $88.64 Million |
CN¥4.41 Billion ≈ $645.86 Million |
-3.63pp |
| 2003-12-31 | 17.35% | CN¥766.20 Million ≈ $112.12 Million |
CN¥4.42 Billion ≈ $646.17 Million |
-11.01pp |
| 2002-12-31 | 28.37% | CN¥715.73 Million ≈ $104.73 Million |
CN¥2.52 Billion ≈ $369.22 Million |
+0.87pp |
| 2001-12-31 | 27.50% | CN¥639.93 Million ≈ $93.64 Million |
CN¥2.33 Billion ≈ $340.56 Million |
+27.40pp |
| 2000-12-31 | 0.10% | CN¥764.65K ≈ $111.89K |
CN¥759.52 Million ≈ $111.14 Million |
-0.71pp |
| 1999-12-31 | 0.81% | CN¥5.55 Million ≈ $811.59K |
CN¥682.04 Million ≈ $99.80 Million |
+0.70pp |
| 1998-12-31 | 0.12% | CN¥697.94K ≈ $102.13K |
CN¥593.19 Million ≈ $86.80 Million |
+0.07pp |
| 1997-12-31 | 0.04% | CN¥200.00K ≈ $29.27K |
CN¥448.72 Million ≈ $65.66 Million |
-- |
About Joincare Pharmaceutical Group Industry Co Ltd
Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China and internationally. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and tradi… Read more